WHY PARTNER?
Because you can’t get this level of access anywhere else
2
50
63%
70+
500+
Our Audience At-A-Glance
Audience by Seniority Level
22% Director
37% C-Level
9% Other
26% VP/SVP/EVP
6% Manager
Audience by Industry
16% Pharmaceutical
6% Technology/Software
43% Biotech
4% CRO
9% Consultant
15% Other
7% Advertising/Marketing Agency
4% Financial Services/Investor
See Who's Already Registered!
52% Are C-Level Executives
- /prompt.
- 23andMe
- AbCellera
- Abdera Therapeutics
- Abdera TX
- Abpro Corp.
- Accent Therapeutics
- Adept Therapeutics
- AdhereTech
- AdvanCell
- Aegle Therapeutics
- Afaxys Inc.
- AffyImmune Therapeutics
- Aikium
- Ailux
- Alector
- Alexion, AstraZeneca Rare Disease
- Alkermes
- Alkeus Pharmaceuticals, Inc.
- Alliance for Regenerative Medicine (ARM)
- Alliance Policy for Regenerative Medicine
- Allogene
- Ally Bridge Group
- Alpha 9 Oncology
- AM Pharma
- Amgen
- Amylyx
- Anbogen Therapeutics
- Gastroenterology at Boston Children’s Hospital
- Ankyra Therapeutics
- AOBiome Therapeutics
- Arbor Biotechnologies
- Arcus Biosciences
- Aronora
- Arrakis Therapeutics
- Arsenal Biosciences
- Astellas Pharma
- AstraZeneca
- Asymchem, Inc.
- Atea Pharmaceuticals, Inc.
- Aurion Biotech
- Avalyn Pharma
- AVEO Oncology
- Avilar Therapeutics
- Axonis Therapeutics
- AZLP
- Banc of California
- Bayer
- Baystate Financial
- Be Biopharma
- BeiGene
- Bexa
- Beyond Celiac Investments
- Bicycle Therapeutics
- Binney Street Capital Venture Fund, Dana-Farber Cancer Institute
- Biocon Limited
- Biogen
- BioJiva
- Biorchestra
- Biosector 2/Syneos Health
- Bitterroot Bio
- bluebird bio
- Blueprint Medicines
- Boehringer Ingelheim USA
- BOLD Longevity Growth Fund
- Bonds Biosystems
- Boyds
- Brand Institute
- BriaCell
- BrickBio
- Bristol Myers Squibb
- BVCF
- Canary Cure
- Caribou Bio
- Cellarity
- Cellino
- Cellphire Therapeutics, Inc
- CerFlux
- CG Oncology
- Chairman of Franklin Biolabs
- Civilization Ventures
- CK Life Sciences
- Clasp Therapeutics
- Clear Scientific, Inc.
- Click Therapeutics
- CMIC
- Coastar Therapeutics
- Codagenix Inc.
- Codexis, Inc.
- Comanche Biopharma
- Cooley
- Cradle Healthcare Co.
- Creacion Ventures
- CSL Seqirus
- Cullinan Oncology
- Cullinan Therapeutics
- CureLab Oncology
- CytoImmune Therapeutics
- Day One Biopharmaceuticals
- Dewpoint Therapeutics
- Dianthus Therapeutics, Inc.
- Disc Medicine
- Discovery Biotech
- dna Communications
- DONG-A America Corp.
- DTRM Biopharma
- EcoR1 Capital
- Editpep
- Eikonoklastes Therapeutics
- Eledon Pharmaceuticals
- ElevateBio BaseCamp
- Eli Lilly
- Eliraz Ventures
- Endeavor
- Entrada Therapeutics
- Eos BioInnovation
- Eurofins CDMO Alphora Inc.
- Evotec; AVIFA Biosciences
- Excision BioTherapeutics
- Extend Biosciences
- Fauna Bio
- Finchley Healthcare Ventures
- Flagship Pioneering
- Foresight Diagnostics
- Formation Bio
- Freenome Holdings, Inc.
- Friends of Cancer Research
- Garuda Therapeutics
- GCI Group
- Genentech
- Geneos Therapeutics
- Genmab
- Geron Corporation
- Gilboa Therapeutics
- Gilead Sciences, Inc
- Gilgamesh Pharma
- Ginkgo Bioworks
- GlobalData
- GlycoMantra
- Good Health Capital
- Graviton Bioscience Corporation
- Great Bay Bio Limited
- Greater Phoenix Economic Council
- Gritstone bio, Inc.
- GS Lab | GAVS
- Guidehouse
- Halloran Consulting Group
- HaloHealth
- HanAll Biopharma
- Harbor Clinical
- HayaTx
- HDAX Therapeutics
- HebeCell
- Heparegenix
- Hepion pharma
- HiFiBiO Therapeutics
- Hogan Lovells
- Hyku Biosciences
- ICaPath
- IDA Ireland
- iECURE
- IFM Therapeutics
- IGM Biosciences
- ILIAD Biotechnologies
- Immuneering Corporation
- Immunis Inc
- ImmunityBio
- IMMUNO CONCEPTS NA LTD
- Immusoft
- IN8bio
- ING Bank
- Innovent
- Innoviva
- insitro
- IQVIA Institute
- Jnana Therapeutics
- JPMorgan
- Jubilant Therapeutics Inc.
- Klick Health
- Kura Oncology
- Laekna Therapeutics
- Larkspur Biosciences
- Legend Biotech
- Lexeo Therapeutics
- Life Biosciences
- Lifecore Biomedical
- Lime Therapeutics
- Lippe Taylor /prompt.
- Lucid Diagnostics
- Luye Pharma Group
- Lysoway Therapeutics, Inc.
- Makovsky
- MapLight Therapeutics
- Mckesson Compile
- MeiraGTx
- Meltemi BioPharma
- Merck
- Metsera
- Mirador Therapeutics
- MMC & RXMOSAIC
- Moderna
- Molecular Partners AG
- MOMA TX
- Monte Rosa Therapeutics
- Morgan, Lewis & Bockius, LLP
- MorphoSys
- Mosaic Biosciences
- Nanobiofab
- Nanoscope
- NapoTherapeutics
- Nasdaq
- National Pharmaceutical Council
- NeoPhore
- neoX Biotech, Inc
- Nerviano Medical Sciences
- Neurogene
- Neuronascent, Inc.
- Neurotech Pharmaceuticals, Inc.
- Nkarta, Inc.
- NodThera
- Novartis
- Novo Nordisk
- Octant, Inc.
- Ocugen
- Olatec Therapeutics
- Organon
- Orion Coporation
- Orum Therapeutics
- Outcome Capital
- Ovid Therapeutics
- PagsGroup
- Pamplona Therapeutics
- Pasithea Therapeutics
- PBM Capital Group
- Pearl Bio
- Pennsylvania Biotechnology Center
- Personalized Stem Cells
- Perspectum
- Pfizer
- Phastar
- PHIOGEN
- PhRMA
- Playground Global
- Portal Instruments
- Poseida Therapeutics
- Precision BioSciences
- Prelude Therapeutics
- Princeton Capital Advisors
- ProJenX, Inc.
- Protean BioDiagnostics
- Pyrotech Therapeutics
- QIAGEN
- quadraScope Ventures
- Qubit Pharmaceuticals
- RA Capital
- Rapport Therapeutics
- Recludix Pharma
- Regency Lifesciences India Pvt Ltd
- Regeneron
- Repare Therapeutics
- Replicate Bioscience
- Replimune
- Resonant Therapeutics
- ReST Tx
- Roivant
- Rosewood Capital Partners
- Roy Consulting
- RS Oncology
- Rubedo Life Sciences
- Sano Genetics
- Sanofi
- Sarcomatrix Therapeutics Corp.
- Sardona Therapeutics
- Schrödinger
- Scient Public Relations
- Scorpion Therapeutics
- Scotia Capital
- Seraxis
- Sionna Therapeutics
- Skipper Bio Med
- Skyhawk Therapeutics
- solascure
- SOTIO
- Sound Bioventures
- Spirovant Sciences Inc.
- Stealth Mode Biotech
- Stingray Therapeutics Inc
- Strand Therapeutics
- STRM.BIO
- Synlogic Therapeutics
- Synthekine
- Systemic Bio
- Takeda
- Takeda Oncology
- Takeda Pharmaceuticals America, Inc.
- Takeda Pharmaceuticals International AG
- Talus Bioscience Inc
- Tarsus Pharmaceuticals
- Test Record
- The Jackson Laboratory
- The Progeria Research Foundation
- Thirona Bio
- Transcend Therapeutics
- Treadwell Therapeutics
- Trivoke Therapeutics
- Uncapped Communications
- University of Texas Austin
- Valley Fever Solutions
- Valo Health, Inc.
- Variant Bio
- Vaxart
- Vedanta Biosciences
- Ventus Therapeutics U.S., Inc.
- Verge Genomics
- Vertex Pharmaceuticals
- Verto Therapeutics
- Viatris
- Vincere Biosciences
- Virginia Tech
- Vitalgenics Inc
- Vivtex Corporation
- Vor Bio
- Vyome Therapeutics Inc
- Vyripharm Biopharmaceuticals
- Waterhouse Brands
- Weber Shandwick
- Wing
- Xalud Therapeutics
- ZEA Biosciences
Connect with Key Stakeholders
Partnering with the Fierce Biotech Summit positions your brand at the forefront of the biotech industry. Engage with top leaders and decision-makers, showcase your innovations, and expand your network. Discover the comprehensive tracks at the Fierce Biotech Summit designed to cover the most pressing and innovative topics in the industry:
- Strategy and Dealmaking
- Early-Stage Development
- PR & Communications (NEW FOR 2024!)
- Preclinical & CMC (NEW FOR 2024!)
Benefits of Partnering
Every day, thousands of executives rely on Fierce Biotech to get news and insights. Our Fierce Biotech editorial team will be bringing together a program of experts to tackle the key issues facing senior biotech executives.
CONNECT
LEARN
NURTURE
Partner opportunities that will help you grow your business!
Thought Leadership: Connect with attendees on an intimate level during one of our hands on roundtable sessions
- Plenary speaking opportunity: Position yourself as a thought leader by delivering a stand-alone plenary session on the topic of your choosing
- Panel speaking opportunity: Get front and center with our audience by participating on a panel discussion about pertinent issues to this community
- Conference roundtables: Connect with attendees on an intimate level during one of our hands on roundtable sessions
Networking: It’s how deals get done
- Tabletop Exhibit Area: Connect with attendees during networking breaks, meals and receptions with an 8 x 10 networking footprint to build out as you choose
- Networking Reception: Connect with attendees at the end of the day at our conference networking reception – share insights from the day’s content.
Branding Opportunities: Add a branding opportunity to any sponsorship
- Registration
- WiFi
- Charging Stations
- Lanyards
- Digital Podium
- Networking Breaks
Expert content from Fierce Biotech editors draw executives
Meet the Fierce Biotech readers in person in Boston this October - our audience will include hundreds of biotech and pharma executives involved in drug development from early stages through FDA approval.
Become a Partner
Solidify existing relationships with clients and build strong connections with new decision-makers.